Flow Space on MSN23h
5 Factors That Make It More Likely You'll Develop Heart Disease
Heart disease has long been considered a man's disease, but the reality is far more complex. Women face unique risks, ...
Chronic inflammation's connection to atrial fibrillation points to IL-1β as a promising treatment target
A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...
Fierce Healthcare2d
How Eko Health is reinventing the stethoscope, aiming to change early detection of heart and lung disease
Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...
Pharmabiz2d
Akura Medical begins patient enrollment in QUADRA-PE study of Katana Thrombectomy System to treat acute pulmonary embolism
Akura Medical begins patient enrollment in QUADRA-PE study of Katana Thrombectomy System to treat acute pulmonary embolism: Los Gatos, California Thursday, February 6, 2025, 18:00 ...
Pulmonaryhypertensionnews.com2d
PAH treatment seralutinib shows benefits over nearly 1.5 years: Trial
In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...
Akura enrols first subject in pulmonary embolism trial of thrombectomy system
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...
Endovascular Today3d
Akura Begins Pivotal Trial of Katana Thrombectomy System in Pulmonary Embolism
Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...
FIRST PATIENT ENROLLED IN AKURA MEDICAL'S US PIVOTAL TRIAL FOR PULMONARY EMBOLISM
Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the first patient enrollment in the QUADRA-PE study (NCT06672510) ...
Korea Joongang Daily on MSN4d
Samsung family donation helps improve odds for patients receiving multiple heart surgeries
Using 3D-printed replicas of patients' hearts based on CT scan results, three professors created model circulation systems ...
Merck to stop lung condition drug study early due to strong efficacy data
Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...
Pulmonaryhypertensionnews.com9d
Right heart size differs between men and women with PAH: Study
Men with PAH had a larger right heart size and worse survival than women, independent of body size and functional status, a ...
Science Daily14d
Novel PET approach identifies early signs of pulmonary arterial hypertension
F-FAPI PET -- can detect the first signs of tissue remodeling in patients with pulmonary arterial hypertension (PAH), providing physicians with an early marker for disease progression. This approach ...